These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10389864)

  • 1. Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.
    Rigberg DA; Centeno J; Kim FS; Ke B; Swenson K; Maggard M; McFadden DW
    J Surg Oncol; 1999 Jun; 71(2):91-6. PubMed ID: 10389864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
    Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
    Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.
    O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
    Dis Esophagus; 1999; 12(2):83-9. PubMed ID: 10466039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
    Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
    Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
    Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
    Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
    Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
    Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
    von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
    Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis.
    Chen Q; Samaranayake LP; Zhen X; Luo G; Nie M; Li B
    Oral Oncol; 1999 Nov; 35(6):548-53. PubMed ID: 10705088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes.
    Jaita G; Candolfi M; Zaldivar V; Zárate S; Ferrari L; Pisera D; Castro MG; Seilicovich A
    Endocrinology; 2005 Nov; 146(11):4737-44. PubMed ID: 16099864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand.
    Noraz N; Gozlan J; Corbeil J; Brunner T; Spector SA
    AIDS; 1997 Nov; 11(14):1671-80. PubMed ID: 9386801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
    Sata M; Suhara T; Walsh K
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas and Fas-ligand expression in human pancreatic cancer.
    Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
    Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.